OLYMPUS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,174 JPY | -0.57% |
|
+3.72% | +6.57% |
| 04-08 | Olympus to Return Land and Building to Shenzhen City Government | MT |
| 03-28 | Olympus Corporation Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024 | CI |
| Sales 2024 * | 930B 5.87B 470B | Sales 2025 * | 989B 6.24B 500B | Capitalization | 2,535B 16B 1,281B |
|---|---|---|---|---|---|
| Net income 2024 * | 259B 1.63B 131B | Net income 2025 * | 110B 695M 55.65B | EV / Sales 2024 * | 2.64 x |
| Net cash position 2024 * | 78.83B 498M 39.85B | Net cash position 2025 * | 127B 799M 64.01B | EV / Sales 2025 * | 2.43 x |
| P/E ratio 2024 * |
10.1
x | P/E ratio 2025 * |
23.5
x | Employees | 32,844 |
| Yield 2024 * |
0.82% | Yield 2025 * |
0.91% | Free-Float | 88.47% |
More Fundamentals
* Assessed data
More news
Latest transcript on Olympus Corporation
More recommendations
More press releases
More news
| 1 day | -0.57% | ||
| 1 week | +3.72% | ||
| Current month | -1.72% | ||
| 1 month | +1.07% | ||
| 3 months | +0.23% | ||
| 6 months | +12.58% | ||
| Current year | +6.57% |
1 week
2 125.50
2 230.00
1 month
2 050.002 293.00
Current year
1 935.502 304.00
1 year
1 782.002 482.50
3 years
1 782.003 198.00
5 years
1 159.003 198.00
10 years
752.503 198.00
| Managers | Title | Age | Since |
|---|---|---|---|
Stefan Kaufmann
CEO | Chief Executive Officer | 56 | 31/03/17 |
Yasuo Takeuchi
CHM | Chairman | 67 | 01/04/80 |
John de Csepel
CTO | Chief Tech/Sci/R&D Officer | - | 02/10/23 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jimmy C. Beasley
BRD | Director/Board Member | 61 | 31/05/19 |
Sumitaka Fujita
BRD | Director/Board Member | 81 | 31/03/12 |
Gary Pruden
BRD | Director/Board Member | 61 | 31/05/22 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.83% | 31 M€ | +11.04% | ||
| 2.11% | 11 M€ | +10.37% | - | |
| 1.55% | 251 M€ | +13.17% | ||
| 1.23% | 31,732 M€ | +14.31% | - | |
| 1.22% | 1,198 M€ | +13.48% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 2,174 | -0.57% | 3,099,200 |
| 25/04/24 | 2,187 | -1.82% | 2,890,300 |
| 24/04/24 | 2,228 | +2.46% | 2,774,700 |
| 23/04/24 | 2,174 | +0.14% | 2,493,400 |
| 22/04/24 | 2,171 | +3.55% | 4,617,300 |
Delayed Quote Japan Exchange, April 26, 2024 at 07:00 am
More quotes
Olympus Corporation specializes in manufacturing and marketing of optical and photographic equipments. Net sales break down by family of products as follows:
- medical equipments (53.1%): surgical endoscopes, ultrasound endoscopes, etc.;
- medical devices (31.7%): medical devices for gastroenterology, urology, respiratory management, ENT and gynecology;
- scientific analysis instruments and microscopes (13.7%);
- other (1.5%): biomedical materials, orthopedic equipment, etc.
Net sales break down geographically as follows: Japan (15.6%), China (14.4%), Asia and Oceania (8.9%), North America (33.8%), Europe (25.1%) and other (2.2%).
Calendar
09/05/2024
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,174
JPY
Average target price
2,430
JPY
Spread / Average Target
+11.75%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.57% | 16.1B | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B | |
| +26.76% | 32.03B |
- Stock Market
- Equities
- 7733 Stock
